Family Medicine · Sterling Heights, MI
NPI
1326250754
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
35200 Dequindre Rd Ste 600
Sterling Heights, MI, 48310
Phone (248) 786-8800
Groups this clinician bills Medicare through
Medicare paid, 2024
$101K
3,003 services
Medicare patients, 2024
144
Average age 72
Drug cost, 2024
$1.0M
11,200 prescriptions
Company payments, 2025
$76.83
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ghazawan K Kashat was code 99458 (e&m - miscellaneous), 363 times for 33 patients. In total Ghazawan K Kashat billed 3,003 services in 73 codes, and Medicare paid $101K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99458 E&M - Miscellaneous | Office | 363 | 33 | $29.70 | $11K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 225 | 18 | $0.08 | $17.7 |
| 99212 Office E&M - Established | Office | 206 | 60 | $39.09 | $8,052 |
| 99214 Office E&M - Established | Office | 191 | 97 | $90.80 | $17K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 190 | 31 | $105.45 | $20K |
| 99457 E&M - Miscellaneous | Office | 179 | 33 | $36.59 | $6,549 |
| 96372 Injection Administration | Office | 166 | 55 | $10.42 | $1,730 |
| 99213 Office E&M - Established | Office | 147 | 69 | $63.47 | $9,331 |
| 36415 Venipuncture Blood Collection | Office | 72 | 47 | $8.65 | $623 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 49 | 21 | $56.60 | $2,773 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 46 | 46 | $18.66 | $858 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 46 | 24 | $0.83 | $38.21 |
| 87426 Immunoassay | Office | 37 | 25 | $34.62 | $1,281 |
| 99497 Care Management/Coordination | Office | 32 | 31 | $63.31 | $2,026 |
| 99203 Office E&M - New | Office | 25 | 25 | $62.32 | $1,558 |
By year: 2022 $37K for 827 services; 2023 $81K for 1,945 services; 2024 $101K for 3,003 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 72 | 47 | $8.65 | $623 |
| 87426 Immunoassay | 37 | 25 | $34.62 | $1,281 |
Medicare prescription drug claims, 2024
In 2024, the drug Ghazawan K Kashat prescribed most often to Medicare patients was Metformin Hcl, with 421 prescriptions and refills. In total Ghazawan K Kashat wrote 11,200 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Generic | 421 | 646 | 63 | $1,813 |
| Atorvastatin Calcium Generic | 374 | 731 | 83 | $2,367 |
| Prednisone Generic | 367 | 367 | 181 | $532 |
| Amlodipine Besylate Generic | 337 | 471 | 58 | $1,113 |
| Famotidine Generic | 322 | 370 | 64 | $2,840 |
| Diclofenac Sodium Generic | 304 | 310 | 88 | $9,084 |
| Lisinopril Generic | 300 | 607 | 60 | $1,680 |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 284 | 424 | 49 | $5,343 |
| Metoprolol Succinate Generic | 262 | 360 | 41 | $2,435 |
| Simvastatin Generic | 261 | 428 | 37 | $1,612 |
| Losartan Potassium Generic | 235 | 415 | 42 | $1,677 |
| Levothyroxine Sodium Generic | 227 | 408 | 41 | $1,987 |
| Vascepa Icosapent Ethyl | 210 | 226 | 29 | $68K |
| Omeprazole Generic | 190 | 295 | 43 | $1,764 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 189 | 192 | 42 | $6,981 |
Brand drugs: 1,612 claims; generic drugs: 9,177 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ghazawan K Kashat $76.83 ($76.83 in general payments such as food, travel and fees) from 2 companies. The largest payer was Exact Sciences Corporation with $59.91.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.